Acceligen Announces Innovative Scientific Paper on Breeding PRRSV Resistant Pigs
EAGAN, Minn., Jan. 16, 2024 /PRNewswire/ -- Acceligen, the leading Precision Breeding company for food animals, today announced publication in Antiviral Research of their groundbreaking work on breeding PRRSV resistant pigs.
- A SUBSIDIARY OF RECOMBINETICS INC., ACCELIGEN ANNOUNCES INNOVATIVE SCIENTIFIC PAPER ON BREEDING PRRSV RESISTANT PIGS
EAGAN, Minn., Jan. 16, 2024 /PRNewswire/ -- Acceligen, the leading Precision Breeding company for food animals, today announced publication in Antiviral Research of their groundbreaking work on breeding PRRSV resistant pigs. - Porcine Reproductive and Respiratory Syndrome Virus, also known as PRRSV, is a virus which results in substantial economic harm to pig farms on a global scale.
- The publication shows that Acceligen is meeting this challenge by uniquely breeding pigs resistant to PRRSV-1 and PRRSV-2.
- Dr. Tad Sonstegard, co-author and CEO of Acceligen said, "The results of this research demonstrate that Acceligen's approach to breed PRRSV resistant pigs opens an alternative avenue for making this trait available to the entire industry."